2.4 Inventories, Recordkeeping & Theft/Loss

2.4 Inventories, Recordkeeping & Theft/Loss

Quick Answer: Perform an initial inventory when controlled-substance activity begins and a biennial inventory at least every two years. Count open CII bottles exactly; open CIII–V bottles may be estimated at ≤1,000 dosage units but need exact counts above that. Keep CS records at least 2 years and readily retrievable. Report theft or significant loss promptly to DEA and document on Form 106. Minnesota may impose stricter operational expectations—use the stricter rule on the MN MPJE.

If prescription rules control the front door of dispensing, inventory and records control the ledger of the closed system. Diversion investigations almost always begin with a broken inventory trail.

Why Inventory and Records Matter

The CSA assumes every controlled dosage unit can be accounted for from manufacturer to patient (or to destruction). Inventory and recordkeeping duties exist so that:

• DEA and the Minnesota Board can audit the pharmacy
• Pharmacists can detect internal theft early
• Ordering (222/CSOS) and dispensing records reconcile
• Significant losses are identified rather than normalized as “shrink”

On the MPJE, inventory items are less about fancy math and more about timing, exact vs estimated counts, retention, and what to do when numbers do not match.

Initial Inventory

When a pharmacy first engages in manufacturing, distributing, or dispensing controlled substances, it must take an initial inventory of all controlled substances on hand. If there are zero CS drugs on day one, the initial inventory still records that fact—document the empty starting point.

The initial inventory is the baseline against which all future acquisitions and dispositions are compared.

Biennial Inventory

After the initial inventory, a registrant must take a new inventory at least every two years (biennial). Practical points:

• You may inventory on any date within two years of the previous inventory date—many pharmacies choose a consistent annual date even though federal law requires only biennial
• The inventory must be maintained in written, typewritten, or printed form (electronic systems must be capable of producing a printable record)
• Inventory is a snapshot of stock on hand at the opening or close of business on the inventory date—be consistent and note whether it is beginning- or end-of-day
• Newly scheduled drugs may require inventory on the effective date of scheduling

Biennial does not mean “only if you feel like it in odd-numbered years.” Missing the window is a compliance failure even if no diversion occurred.

Exact Count vs Estimated Count

Federal count precision depends on schedule and container status:

Schedule II

• Exact count of all CII substances is required
• For open containers, do not estimate CII tablets or patches—count them

Schedules III, IV, and V

• An estimated count is allowed for open containers of ≤ 1,000 tablets/capsules (or similar dosage units)
• An exact count is required if the open container holds more than 1,000 dosage units
• Sealed, unopened manufacturer bottles can be recorded by the labeled count without breaking the seal for counting (still document properly)

Exam trap: estimating an open bottle of oxycodone because “counting takes too long.” CII exact-count rules do not yield to convenience.

What the inventory record should identify

For each CS product, inventory records typically capture:

• Drug name
• Dosage form and strength
• Number of units/volume
• Number of containers as applicable
• Whether the inventory was taken at opening or close of business
• Date and identity/signature of the person(s) responsible as required by policy and law

Separate CII inventory information from CIII–V in a way that keeps CII records readily identifiable (many pharmacies maintain a separate CII inventory section).

Recordkeeping System: The Paper (and Electronic) Closed Loop

Federal law requires registrants to keep complete and accurate records of each controlled substance received, sold, delivered, or otherwise disposed of. For a community pharmacy, the core file set includes:

1. Executed Form 222 / CSOS order records for CI/CII acquisition
2. Invoices and packing documents for CIII–V receipts (and commercial docs supporting CII receipts alongside 222/CSOS)
3. Prescriptions (hard copy or compliant electronic) and dispensing/refill records
4. Inventories (initial, biennial, and any special inventories)
5. Disposal/destruction documentation (including Form 41 pathway records)
6. Theft/loss reports (Form 106 and related notices)
7. Power of attorney documents for ordering authority

Retention period

Federally, required CS records must be kept at least two years from the date of the record. Minnesota or corporate policy may require longer retention—if the exam contrasts periods, prefer the period that keeps you compliant with both, which means at least as long as the stricter rule.

Readily retrievable

Records must be kept available for inspection. “Readily retrievable” generally means CIII–V records can be separated from other records by asterisk, red line, electronic query, or similar system without an archaeological dig. CII records are often maintained separately. A pharmacist who cannot produce last year’s CII 222s during an inspection is already in trouble.

Central recordkeeping

Some records may be maintained at a central location if DEA is properly notified and the pharmacy can still produce them on the required timeline. Exam takeaway: central storage is a regulated privilege, not an excuse for “corporate has it somewhere.”

Acquisitions and Dispositions: Reconciling the Math

A simple accountability equation drives investigations:

Beginning inventory + receipts − dispensing/disposals/transfers = ending inventory

If perpetual inventory software says 40 hydromorphone tablets should be present and the count shows 28, you have a variance. Variances demand:

• Recheck math and data entry
• Review recent prescriptions and returns
• Review receiving logs and CSOS/222 completions
• Review waste/destruction and reverse-distributor paperwork
• Assess theft potential and security-camera footage
• Determine whether the loss is significant

Do not “adjust perpetual to match physical” without investigation. Silent adjustments are how diversion hides for months.

Theft and Significant Loss Response

Discovery triggers duty

The clock starts when the registrant discovers the theft or significant loss—not when the monthly accounting meeting happens to notice a trend. Train staff to escalate immediately.

Required federal response pattern

1. Protect the scene of an obvious break-in; preserve evidence
2. Notify DEA in writing within one business day of discovery of theft or significant loss (classic exam timing)
3. Notify local law enforcement as appropriate
4. Conduct a good-faith investigation to quantify missing drugs by NDC/strength
5. Submit DEA Form 106 with the theft/loss details
6. Implement corrective controls (access changes, camera review process, dual counts, termination of access credentials)
7. Maintain copies of all notices and the Form 106 in the record system for the retention period

Significant loss judgment factors

Significance is qualitative and quantitative. Consider schedule, quantity, drug attractiveness for abuse, whether losses are recurring, and whether the amount is explainable by ordinary counting error. Repeated “small” CII shortages can be significant in aggregate. When unsure, investigate and document rather than hoping the next shipment hides the hole.

In-transit loss vs on-site loss

If a CII tote never arrives, determine whether custody had transferred to the pharmacy. Responsibility for reporting can depend on where in the supply chain the loss occurred. Exam stems often give enough facts to decide whether the pharmacy had already received and signed for the drugs.

Destruction and Reverse Distribution Records

Expired, damaged, or unwanted pharmacy stock controlled substances should move through lawful channels (often a DEA-registered reverse distributor) with complete chain-of-custody documentation. Form 41 relates to destruction accountability. Patient returned medications, if collected, must follow authorized collector rules—do not commingle street returns into pharmacy stock or informal employee disposal.

Minnesota Practice Overlay

Federal inventory and two-year retention are the national floor. For MN MPJE performance:

• Expect the Minnesota Board to care about PIC oversight, security (Rule-based operations), and whether the pharmacy’s real controls match its paperwork
• Diversion, unresolved variances, and late reporting can become professional conduct issues, not only DEA paperwork issues
• Dispensing records interact with §152.126 PMP reporting completeness for Schedules II–V, butalbital, and gabapentin—inventory compliance does not excuse PMP nonreporting, and vice versa
• If a Minnesota record retention or reporting expectation is stricter than the federal two-year/biennial floor, choose the stricter compliance path

Inspection-Day Readiness Checklist

A well-run Minnesota pharmacy should be able to produce quickly:

• Most recent biennial (or more frequent) CS inventory with CII exact counts
• Executed 222/CSOS records for recent CII receipts
• CIII–V invoices
• Hard-copy or electronic CS prescriptions for the requested period
• POA documents for purchasers
• Any Form 106 filings and related police/DEA notices
• Destruction/reverse-distributor files
• Perpetual inventory exception reports and resolution notes for high-risk CIIs

If any of those are missing, the closed system is only closed on paper.

Worked Example

A pharmacy’s last inventory was dated July 15, 2024. The next federal biennial deadline is no later than July 15, 2026. On June 1, 2026, staff count CII opioids exactly and estimate open bottles of zolpidem that contain 500 tablets, but exactly count an open bottle of a CIII product that still holds 1,200 tablets. Two weeks later, perpetual inventory shows 10 fentanyl patches missing after a staffing change. The PIC investigates the same day, confirms a significant loss, notifies DEA within one business day, files Form 106, resets safe access credentials, and documents corrective action. That sequence is what exam writers want—not a quiet perpetual adjustment three months later.

Common Traps

• Treating biennial inventory as optional if perpetual software exists
• Estimating open CII bottles
• Estimating open CIII–V bottles over 1,000 units
• Keeping records for “about a year” because corporate backups “probably exist”
• Filing Form 41 for a burglary or Form 106 for routine reverse distribution
• Waiting for absolute certainty before making the one-business-day DEA notice when theft is already clear
• Answering with the federal floor when a Minnesota vignette states a stricter retention or reporting duty

Inventory, records, and theft reporting convert abstract CSA theory into auditable daily practice. Master the biennial cycle, exact-count rules, two-year retention, and Form 106 timing, then keep Minnesota’s stricter-when-applicable mindset for every operations item that follows in this guide.